CureVac
Lea Rudolph is a seasoned finance professional with extensive experience in finance management and project coordination across several companies. Currently serving as a Senior Finance Expert for ESG/EIP and Senior Project Manager at CureVac since April 2022, previous roles include Commercial Project Manager at SOWITEC GROUP from September 2019 to March 2022 and positions at Bosch and Eissmann Group Automotive. Educational credentials include a Master of Arts in Controlling, Finance, and Accounting from Pforzheim University and a Bachelor of Applied Science in International Business from ESB Business School, complemented by an international academic experience at Pontificia Universidad Católica de Chile.
This person is not in any teams
This person is not in any offices
CureVac
7 followers
CureVac is a global biopharmaceutical company in the field of messenger RNA (mRNA) technology, with more than 20 years of expertise in developing and optimizing the versatile biological molecule for medical purposes. The principle of CureVac’s proprietary technology is the use of non-chemically modified mRNA as a data carrier to instruct the human body to produce its own proteins capable of fighting a broad range of diseases.